{"database": "openregs", "table": "federal_register", "rows": [["2020-01072", "Product-Specific Guidance for Levonorgestrel; Intrauterine Device; Revised Draft Guidance for Industry; Availability", "Notice", "The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a revised draft guidance for industry, entitled \"Draft Guidance for Levonorgestrel.\" The revised draft guidance, when finalized, will provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for a levonorgestrel intrauterine device.", "2020-01-23", 2020, 1, "https://www.federalregister.gov/documents/2020/01/23/2020-01072/product-specific-guidance-for-levonorgestrel-intrauterine-device-revised-draft-guidance-for-industry", "https://www.govinfo.gov/content/pkg/FR-2020-01-23/pdf/2020-01072.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a revised draft guidance for industry, entitled \"Draft Guidance for Levonorgestrel.\" The revised draft guidance, when finalized, will provide product-specific...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2020-01072"], "units": {}, "query_ms": 48.06976008694619, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}